MedPath

Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation

Not Applicable
Completed
Conditions
PTSD
Fear
Panic Disorder
Interventions
Device: Amygdala recording and stimulation using Neuropace RNS
Behavioral: Behavioral tasks
Registration Number
NCT03958903
Lead Sponsor
Stanford University
Brief Summary

This study aims to specifically examine the in vivo electrophysiology and effects of direct stimulation of the human amygdala during conditioned and evoked fear. Investigators will also examine amygdala electrophysiology and the effects of stimulation during tasks to examine the effects of reward on fear memory.

This study will recruit subjects with a history of temporal lobe epilepsy (TLE) who have undergone neurosurgical implantation with FDA-approved, NeuroPace RNS devices for treatment of seizures. These patients provide a unique cohort with (Responsive Neurostimulation) RNS devices capable of both recording and stimulating the amygdala during performance of fear-based, behavioral tasks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • be between age 18-65 years of age
  • participants must have received the Neuropace RNS implant to treat their seizures
  • have comprehension of instructions in the English language
  • be on a stable dose of medications for their epilepsy
  • have received the RNS System for Temporal Lobe Epilepsy
  • have capacity to provide informed consent
Read More
Exclusion Criteria
  • significant cognitive impairment (Mini Mental Status Examination score of less than 20)
  • DSM-V diagnosis of alcohol/substance abuse (except nicotine) within the last month or a diagnosis of alcohol/substance dependence (except nicotine) within the last 6 months
  • Unable to apply EEG cap
  • History of traumatic brain injury
  • Active or high suicide risk
  • Unable to come to study site/lack of stable housing
  • is pregnant or nursing
  • Patient's treating neurologist determines that the patient's epilepsy is not stable enough to participate in this study
  • Any condition (including psychiatric) which in the judgment of the Investigator would prevent the subject from completion of the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Neurophysiological recording and stimulation of amygdalaAmygdala recording and stimulation using Neuropace RNSRecording and stimulation of amygdala using Neuropace RNS devices at certain points through out the behavioral tasks.
Neurophysiological recording and stimulation of amygdalaBehavioral tasksRecording and stimulation of amygdala using Neuropace RNS devices at certain points through out the behavioral tasks.
Primary Outcome Measures
NameTimeMethod
ECoG (ElectroCorticoGraphy) frequency changes2 days

Quantify changes in ECoG measures as determined clinically by the Investigator using intracranial recordings from the Neuropace devices.

Analyze changes in ECoG frequency - in resting state and ECoG throughout task and stimulation

EEG(electroencephalography) frequency changes2 days

Analyze changes in frequency in Hertz- in resting state EEG recording and EEG recording across all the tasks as determined clinically by the Investigator.

Investigators will be analyzing stimulus-induced electrophysiological recordings, focusing on Event-Related Spectral Potentials (ERSP).

ECoG (ElectroCorticoGraphy) amplitude changes2 days

Quantify changes in ECoG measures as determined clinically by the Investigator.- using intracranial recordings from the Neuropace devices.

Analyze changes in ECoG amplitude- in resting state and ECoG throughout task and stimulation.

EEG(electroencephalography) amplitude changes2 days

Analyze change in amplitude in microvolts -in resting state EEG recording and EEG recording across all the tasks as determined clinically by the Investigator.

Investigators will be analyzing stimulus-induced electrophysiological recordings, focusing on Event-Related Potentials (ERPs).

Secondary Outcome Measures
NameTimeMethod
Electrophysiological changes in EMG2 days

Analyze changes in amplitude of electromyography (EMG) from resting state to EMG recordings across all tasks.

Electrophysiological changes in EDA2 days

Analyze changes in amplitude of electrodermal activity (EDA) from resting state to EMG recordings across all tasks.

Trial Locations

Locations (1)

Stanford University

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath